par Van Slambrouck, Séverine;Parmar, Virinder S.;Sharma, Sunil K.;De Bondt, Bart;Foré, Fleur;Coopman, Peter;Vanhoecke, Barbara W.;Boterberg, Tom;Depypere, Herman T.;Leclercq, Guy 
;Bracke, Marc E.
Référence FEBS letters, 579, 7, page (1665-1669)
Publication Publié, 2005-03
;Bracke, Marc E.Référence FEBS letters, 579, 7, page (1665-1669)
Publication Publié, 2005-03
Article révisé par les pairs
| Résumé : | Tangeretin is a methoxyflavone from citrus fruits, which inhibits growth of human mammary cancer cells and cytolysis by natural killer cells. Attempting to unravel the flavonoid's action mechanism, we found that it inhibited extracellular-signal-regulated kinases 1/2 (ERK1/2) phosphorylation in a dose- and time-dependent way. In human T47D mammary cancer cells this inhibition was optimally observed after priming with estradiol. The spectrum of the intracellular signalling kinase inhibition was narrow and comparison of structural congeners showed that inhibition of ERK phosphorylation was not unique for tangeretin. Our data add tangeretin to the list of small kinase inhibitors with a restricted intracellular inhibition profile. © 2005 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved. |
